B11 Week 10

Cards (37)

  • Gene therapies
    Use introduction/alteration of DNA sequences to create a therapeutic benefit
  • Gene therapies are not new, but CRISPR/Cas9 is making this much easier and more precise, which is opening up new possibilities
  • Gene therapies using viruses to introduce new DNA sequences to integrate randomly into the genome have been around for awhile and are still used routinely
  • Regenerative medicine

    Seeks to restore tissue structure and function and provide options for what were previously untreatable injuries or diseases
  • Regenerative medicine approaches can involve cell therapy, gene therapy, and/or tissue bioengineering
  • Sickle cell disease
    An inherited blood disorder caused by a single nucleotide change that alters a single amino acid in the gene for β-globin, a subunit in hemoglobin, causing abnormal clumped protein fibers
  • CRISPR gene therapy for sickle cell disease
    Patient's hematopoietic stem cells are isolated and edited to correct the single nucleotide change, then re-introduced to the patient after chemotherapy to remove existing unedited hematopoietic stem cells
  • Induced pluripotent stem cells (iPSCs)
    Discovered in 2012, these are master regulators of pluripotency
  • Cord blood is FDA approved as a source of hematopoietic stem cells to treat diseases of the blood/immune system (ex. leukemia and sickle cell anemia)
  • The only stem cell products that are FDA-approved for use in the United States consist of blood-forming stem cells
  • Autocrine, juxtracrine, and endocrine signaling pathways
    Types of cell-to-cell communication
  • Cell surface vs nuclear receptors
    • Cell surface receptors mediate rapid signaling responses, nuclear receptors are transcription factors that regulate gene expression
  • ECM and integrin signaling can influence cell function and cell survival
  • Morphogens
    Signaling molecules that influence cell fate in a concentration-dependent manner
  • Signaling mechanisms
    1. Phosphorylation
    2. GTP binding
  • Mutations in signaling pathways
    Can produce oncogenes with uncontrolled signaling
  • Gene regulation occurs at the post-translational level
  • Molecular chaperones
    Assist protein folding to the correct and most stable form
  • Molecular chaperones
    • Heat shock proteins (hsps)
  • Misfolded proteins are degraded by proteasomes
  • Proteasomes
    Abundant sites for protein degradation, with protease activity isolated inside a hollow cylinder
  • Proteins can be marked for proteasomal degradation by addition of a polyubiquitin chain
  • Ubiquitin
    A small protein that can be covalently added to different sites on proteins by ubiquitin ligases to regulate their function
  • Regulation of protein degradation
    1. Signals activate ubiquitin ligase complexes
    2. Ubiquitinated proteins are sent to the proteasome for degradation
  • Post-translational modifications allow rapid changes in protein activity, localization, and stability
  • Signaling pathways are interconnected and can branch out to impact many cell functions
  • Endocrine, paracrine, and juxtacrine signaling
    Types of intercellular communication
  • Nuclear receptors
    Transcription factors that translocate to the nucleus upon ligand binding
  • Receptors expressed and signals received determine cell function
  • Integrins
    Transmembrane proteins that help cells adhere to the extracellular matrix and transmit signals
  • Anoikis is apoptosis due to loss of integrin-mediated cell adhesion
  • Mammary epithelial cells
    • Extracellular matrix signals direct normal structure and function
  • Signaling responses can be "fast" (protein modification) or "slow" (gene expression)
  • Positive and negative feedback in signaling pathways

    Shapes the duration and dynamics of signaling
  • GTPases
    Molecular switches in signaling pathways, with GTP-bound form being active
  • Kinases and phosphatases
    Enzymes that add and remove phosphate groups, creating molecular switches
  • Mutations affecting GTPase or kinase signaling are common in cancer and can create oncogenes